Sai Life Sciences Overview
- Year Founded
-
1999
- Status
-
Public
- Employees
-
5,224
- Stock Symbol
-
SAILIFE
- Investments
-
3
- Share Price
-
$19.13
- (As of Thursday Closing)
Sai Life Sciences General Information
Description
Sai Life Sciences Ltd conducts contract research, development, and manufacturing activities for customers in the pharmaceutical and biotechnology industries. The Company offers Contract Research Organisation (CRO) and Contract Development and Manufacturing Organization (CDMO) capabilities for small molecules, providing integrated discovery, development and manufacturing services spanning medicinal chemistry, process development, clinical manufacturing and commercial manufacturing. The Company has one reportable segment, Contract research, development and manufacturing. It operates in India and outside India, with the maximum revenue coming from outside India.
Contact Information
Website
www.sailife.comCorporate Office
- Plot Number DS-7, ICICI knowledge Park, Turkapally (v)
- Shameerpet, Mandal, Medchal -Malkajgiri Dist
- Hyderabad, Telangana 500078
- India
Corporate Office
- Plot Number DS-7, ICICI knowledge Park, Turkapally (v)
- Shameerpet, Mandal, Medchal -Malkajgiri Dist
- Hyderabad, Telangana 500078
- India
Sai Life Sciences Stock Performance
As of 19-Nov-2026, Sai Life Sciences’s stock price is $19.13. Its current market cap is $4.07B with 212M shares.
(As of Thursday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $19.13 | $19.13 | $8.64 - $20.79 | $4.07B | 212M | 1.08M | $0.19 |
Sai Life Sciences Financials Summary
As of 30-Sep-2026, Sai Life Sciences has a trailing 12-month revenue of $256M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2026 31-Mar-2026 | FY 2025 31-Mar-2025 | FY 2024 31-Mar-2024 |
|---|---|---|---|---|
| EV | 3,381,811 | 2,177,268 | 1,941,508 | |
| Revenue | 255,770 | 241,822 | 196,363 | 175,932 |
| EBITDA | 77,891 | 73,975 | 50,247 | 36,357 |
| Net Income | 40,576 | 39,486 | 20,120 | 10,003 |
| Total Assets | 437,503 | 384,318 | 369,418 | 272,819 |
| Total Debt | 64,504 | 30,572 | 41,195 | 111,239 |
Sai Life Sciences Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
Sai Life Sciences Comparisons
Industry
Financing
Details
Sai Life Sciences Competitors (20)
One of Sai Life Sciences’s 20 competitors is Anthem Biosciences, a Formerly PE-Backed company based in Bengaluru, India.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Anthem Biosciences | Formerly PE-Backed | Bengaluru, India | ||||
| Nuvisan | Formerly PE-Backed | Neu-Ulm, Germany | ||||
| Curia | Private Equity-Backed | Albany, NY | ||||
| BioDuro-Sundia | Private Equity-Backed | Irvine, CA | ||||
| Vimta Labs | Corporation | Hyderabad, India |
Sai Life Sciences Patents
Sai Life Sciences Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-RE48622-E1 | Therapeutically active pyrazolo-pyrimidine derivatives | Inactive | 20-Dec-2012 |
Sai Life Sciences Signals
Sai Life Sciences Investors
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Contact Info |
|---|
Sai Life Sciences Investments & Acquisitions (3)
Sai Life Sciences’s most recent deal was a Merger/Acquisition with Prasad Drugs. The deal was made on 01-Jun-2005.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| Prasad Drugs | 01-Jun-2005 | Merger/Acquisition | Other Chemicals and Gases | ||
| Merrifield Pharma | 01-Jan-2005 | Merger/Acquisition | Pharmaceuticals | ||
| Sai Life Sciences (Two Manufacturing Facilities in India) | 01-Jan-2004 | Corporate Asset Purchase | Buildings and Property |
Sai Life Sciences ESG
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
Rank
Percentile
Commercial Services
Industry
Rank
Percentile
Business Support Services
Subindustry
Rank
Percentile
Sai Life Sciences FAQs
-
When was Sai Life Sciences founded?
Sai Life Sciences was founded in 1999.
-
Where is Sai Life Sciences headquartered?
Sai Life Sciences is headquartered in Hyderabad, India.
-
What is the size of Sai Life Sciences?
Sai Life Sciences has 5,224 total employees.
-
What industry is Sai Life Sciences in?
Sai Life Sciences’s primary industry is Other Healthcare Services.
-
Is Sai Life Sciences a private or public company?
Sai Life Sciences is a Public company.
-
What is Sai Life Sciences’s stock symbol?
The ticker symbol for Sai Life Sciences is SAILIFE.
-
What is the current stock price of Sai Life Sciences?
As of 19-Nov-2026 the stock price of Sai Life Sciences is $19.13.
-
What is the current market cap of Sai Life Sciences?
The current market capitalization of Sai Life Sciences is $4.07B.
-
What is Sai Life Sciences’s current revenue?
The trailing twelve month revenue for Sai Life Sciences is $256M.
-
Who are Sai Life Sciences’s competitors?
Anthem Biosciences, Nuvisan, Curia, BioDuro-Sundia, and Vimta Labs are some of the 20 competitors of Sai Life Sciences.
-
What is Sai Life Sciences’s annual earnings per share (EPS)?
Sai Life Sciences’s EPS for 12 months was $0.19.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process